NexMed, Inc. (NASDAQ: NEXM), a specialty CRO with a pipeline of products based on the NexACT
technology, today announced the expansion of its senior business development team within NexMed (U.S.A.), with the appointments of Linda Smibert as Vice President of Business Development and Mark S. Wilson as Vice-President of Technology Development. Both executives will report to Vivian Liu, the Company’s Executive Vice-President.
In her new position, effective May 26, 2010, Ms. Smibert will spearhead the out-licensing of NexMed’s pre-clinical and clinical product pipeline. Prior to joining the Company, Ms. Smibert served for eight years as Senior Director and Director of Business Development at Santarus, Inc., where she led licensing deals with GlaxoSmithKline and Norgine, a co-promotion arrangement with Otsuka America, and contributed to alliances with Schering-Plough and others. Ms. Smibert has over 20 years of experience in the pharmaceutical industry, and, in addition to her tenure at Santarus, has held a variety of business development and strategic planning management functions at Bristol-Myers Squibb in the U.S. and in Canada, as well as with Zeneca in Canada and the U.K. Ms. Smibert earned her B.A. from the University of British Columbia and an MBA from the University of Toronto.
In his new position, effective May 24, 2010, Mr. Wilson is responsible for the out-licensing of the NexACT technology. Mr. Wilson brings to NexMed over 20 years of experience in the biopharmaceutical, diagnostic and medical device industries. Prior to joining NexMed, he was Entrepreneur-in-Residence at CONNECT in San Diego, where he provided business start-up strategy, development and sourcing consulting services to local companies. Prior to that, he served for five years as Vice President of Business Development at Halozyme Therapeutics, where, among others, he was responsible for initiating the company’s $612 million alliance with F. Hoffmann-La Roche and for various alliances with Baxter Healthcare. Mr. Wilson earned a B.S. in Mechanical Engineering from the University of California, Berkeley, and an MBA from the University of California, Los Angeles.